Cohort characteristics matched known clinical phenomena in human steatosis and MASH, including steadily rising transaminases (ALT>AST) across the fibrosis stage before declining in the setting of cirrhosis, and PT-INR which becomes abnormal at the cirrhosis stage. This evidence concerns the gene GPT and steatosis.